SERB Pharmaceuticals Acquires Y-mAbs Therapeutics
SERB Pharmaceuticals acquired Y-mAbs Therapeutics for $412.0M. View deal terms, timeline, and press on Fsome.
Deal Details
- Acquirer
- SERB Pharmaceuticals
- Acquired Company
- Y-mAbs Therapeutics
- Price
- $412.0M
- Acquisition Type
- Merger
- Announced
- August 5, 2025
Canonical: https://fsome.com/acquisitions/serb-pharmaceuticals-acquires-y-mabs-therapeutics-8235032 · For the full deal terms, timeline, and press references, please enable JavaScript.